Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
Purpose: To determine the safety, efficacy, and tolerability of combinations of pilocarpine (Pilo) and oxymetazoline (Oxy) ocular drops dosed once daily and identify the optimal concentration of each for the pharmacologic treatment of presbyopia. Design: Two concurrent Phase 2, multicenter, double-m...
Enregistré dans:
Auteurs principaux: | Francis W. Price, Jr., MD, Milton Hom, OD, Majid Moshirfar, MD, David Evans, OD, Haixia Liu, MD, PhD, Jeff Penzner, PharmD, Michael R. Robinson, MD, Sungwook Lee, PhD, David L. Wirta, MD |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3ff05453a3a427e87ac7613d6ea841d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Presbyopia Treatments by Mechanism of Action: A New Classification System Based on a Review of the Literature
par: Chang DH, et autres
Publié: (2021) -
FEATURES OF VISUAL PERCEPTION IN PATIENTS WITH PRESBYOPIA, DEPENDING ON THE TYPE OF INTRAOCULAR CORRECTION
par: A. G. Shchuko, et autres
Publié: (2016) -
Maximum human objectively measured pharmacologically stimulated accommodative amplitude
par: Grzybowski A, et autres
Publié: (2018) -
Characterization of mouse salivary polypeptide secretion after oral administration of pilocarpine
par: LÓPEZ-SOLÍS,REMIGIO, et autres
Publié: (2001) -
Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy
par: Alexandre Vigier, et autres
Publié: (2021)